BioCentury
ARTICLE | Clinical News

Iroko reports Phase III pain data for submicron indomethacin

December 8, 2012 1:35 AM UTC

Iroko Pharmaceuticals LLC (Philadelphia, Pa.) said in a Phase III trial to treat post-surgical acute pain that all three doses of submicron indomethacin met the primary endpoint of reducing pain inten...